期刊文献+

50例妇科恶性肿瘤诊治体会分析

Analysis of Diagnosis and Treatment of 50 Cases With Gynecologic Malignant Tumor
下载PDF
导出
摘要 目的 研究妇科恶性肿瘤的诊治情况。方法 我院选择2013年7月-2015年7月诊治的50例妇科恶性肿瘤患者,对其诊治情况进行分析。结果 所选的50例患者中,在本院接受放化疗及手术治疗的有43例,其中5例转院,2例放弃治疗。转院的5例患者平均年龄在(46.2±3.1)岁,其中内膜癌和卵巢癌患者的年龄超过60岁。结论 随着妇科肿瘤发病率的逐渐增加,而且向着年轻化方向发展,需要妇科肿瘤医师对肿瘤整个过程进行关注,加强各级预防措施,掌握肿瘤临床中提出的新观点和新理念,用于指导临床工作,提升医疗质量。 Objective To study the diagnosis and treatment of gynecological malignant tumor. Methods 50 cases of gynecologic malignant tumor patients treated in our hospital from July2013 to July 2015 were analyzed. Results Selected 50 cases of patients,in the hospital received radiotherapy,chemotherapy and surgery in the treatment of 43 cases,of which 5 were transferred,2 cases gave up treatment. The average age of the 5 patients in the hospital(46.2±3.1)years old, the patients with endometrial cancer and ovarian cancer over the age of 60. Conclusion With the gradual increase in the incidence of gynecological cancer, and the development of the younger,the need for gynecological tumor physicians to focus on the whole process of tumor,strengthen prevention measures at al levels,to grasp the new ideas and new ideas presented in clinical practice,to guide clinical work,improve medical quality.
作者 张广枚
出处 《中国卫生标准管理》 2015年第25期34-35,共2页 China Health Standard Management
关键词 妇科恶性肿瘤 临床诊治 Gynecologic malignant tumor Clinical diagnosis and treatment
  • 相关文献

参考文献3

二级参考文献28

  • 1Prat J. Prognostic parameters of endometrial carcinoma [ J ]. Hum Pathol,2004,35 ( 6 ) :649-662.
  • 2Barlin JN, Zhou Q, St Clair CM, et al. Classification and regression tree (CART) analysis of endometrial carcino- ma:Seeing the forest for the itches [ J]. Gynecol Oncol, 2013,130(3) :452-456.
  • 3Revankar CM, Ciminc, DF. Sklar IA. etal. A transmem- brane iniracellular estrogen receptor mediates rapid cell signaling [J]. Science, 2005,307 ( 5715 ) : 1625-1630.
  • 4Du GQ,Zhou L, Chert XY, et al. The G protein-coupled re- ceplor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells [ J ]. Biochem Biophys Res Commun, 2012,420 ( 2 ) : 343 -349.
  • 5Ignatov T, Eggemann H,Semczuk A,et al. Role of GPR30 in endometrial pathology after tamoxifen for breast cancer [J]. Am J Obstet Gynecol.2010,203(6) :595. e9-e16.
  • 6Han G,Li F,Yu X,et al. C;PER:a novel target for non-genomic estrogen action in the cardiovascular system [ J ]. Phannacol Res,2013,71 ( l ) :53-60.
  • 7Samartzis N, Samartzis EP, Noske A, et al. Expression of the G protein-coupled estrogen receptor ( GPER ) in en- dometriosis: a tissue microarray study [ J ]. Reprod Biol Endocrino1,2012 ,10 :30.
  • 8Smith HO, Leslie KK, Singh M, et al. GPR30:a novel indi- cator of poor survival for endometrial carcinoma[ J]. Am J Obstet Gynecol,2007,196 (4) :386. e1-e9.
  • 9Filardo E J, Graeber CT, Quinn JA, et al. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopath- ologic determinants of tumor progression [ J ]. Clin Cancer Res ,2006,12(21 ) :6359-6366.
  • 10Bologa CG, Revankar CM, Young SM, et al. Virtual and biomolectdar screening converge on a selective agonist for GPR30 [ J ]. Nat Chem Biol, 2006,2 ( 4 ) : 207-212.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部